Norges Bank’s Thermo Fisher Scientific TMO Stock Holding History

Norges Bank’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,302,863	Closed	-$3.07B	–	1278
2025 Q4	$3.07B	Buy	+5,302,863	New	+$3B	0.33%	45
2025 Q3	–	Sell	-5,585,297	Closed	-$2.26B	–	1427
2025 Q2	$2.26B	Sell	5,585,297 -602,297	-10%	-$252M	0.28%	59
2025 Q1	$3.08B	Buy	6,187,594 +133,053	+2%	+$72.1M	0.43%	35
2024 Q4	$3.15B	Buy	6,054,541 +462,575	+8%	+$254M	0.41%	35
2024 Q3	$3.46B	Buy	5,591,966 +20,784	+0.4%	+$12.3M	0.48%	33
2024 Q2	$3.08B	Sell	5,571,182 -359,703	-6%	-$206M	0.46%	35
2024 Q1	$3.45B	Buy	5,930,885 +449,387	+8%	+$252M	0.54%	28
2023 Q4	$2.91B	Sell	5,481,498 -670,806	-11%	-$325M	0.51%	30
2023 Q3	$3.11B	Sell	6,152,304 -475,629	-7%	-$253M	0.63%	22
2023 Q2	$3.46B	Buy	6,627,933 +698,133	+12%	+$377M	0.68%	21
2023 Q1	$3.42B	Buy	5,929,800 +290,189	+5%	+$164M	0.75%	17
2022 Q4	$3.11B	Buy	5,639,611 +63,481	+1%	+$33.6M	0.75%	18
2022 Q3	$2.83B	Buy	5,576,130 +156,086	+3%	+$87.4M	0.75%	16
2022 Q2	$2.94B	Buy	5,420,044 +319,546	+6%	+$176M	0.76%	16
2022 Q1	$3.01B	Buy	5,100,498 +928,043	+22%	+$533M	0.66%	20
2021 Q4	$2.78B	Buy	4,172,455 +68,591	+2%	+$42.8M	0.57%	22
2021 Q3	$2.34B	Sell	4,103,864 -102,646	-2%	-$56.3M	0.52%	32
2021 Q2	$2.12B	Sell	4,206,510 -258,613	-6%	-$122M	0.46%	36
2021 Q1	$2.04B	Sell	4,465,123 -551,495	-11%	-$263M	0.47%	40
2020 Q4	$2.34B	Buy	5,016,618 +208,336	+4%	+$97.7M	0.55%	29
2020 Q3	$2.12B	Buy	4,808,282 +113,627	+2%	+$46.9M	0.56%	30
2020 Q2	$1.7B	Sell	4,694,655 -18,151	-0.4%	-$6.08M	0.49%	37
2020 Q1	$1.34B	Buy	4,712,806 +367,673	+8%	+$116M	0.48%	40
2019 Q4	$1.41B	Buy	4,345,133 +251,828	+6%	+$76.4M	0.39%	43
2019 Q3	$1.19B	Buy	4,093,305 +165,160	+4%	+$47.3M	0.37%	48
2019 Q2	$1.15B	Sell	3,928,145 -250,474	-6%	-$69M	0.36%	51
2019 Q1	$1.14B	Sell	4,178,619 -49,813	-1%	-$12.4M	0.37%	49
2018 Q4	$946M	Buy	4,228,432 +239,752	+6%	+$56.3M	0.35%	53
2018 Q3	$974M	Buy	3,988,680 +43,271	+1%	+$9.95M	0.32%	60
2018 Q2	$817M	Sell	3,945,409 -56,670	-1%	-$12M	0.28%	67
2018 Q1	$826M	Sell	4,002,079 -283,814	-7%	-$59.6M	0.3%	62
2017 Q4	$814M	Sell	4,285,893 -87,433	-2%	-$16.7M	0.29%	59
2017 Q3	$827M	Buy	4,373,326 +359,382	+9%	+$65.1M	0.31%	59
2017 Q2	$700M	Buy	4,013,944 +151,341	+4%	+$25.4M	0.28%	72
2017 Q1	$593M	Buy	3,862,603 +71,959	+2%	+$11M	0.24%	76
2016 Q4	$535M	Buy	3,790,644 +73,367	+2%	+$10.8M	0.23%	80
2016 Q3	$565M	Sell	3,717,277 -108,600	-3%	-$16.7M	0.27%	73
2016 Q2	$565M	Buy	3,825,877 +321,838	+9%	+$47.5M	0.27%	73
2016 Q1	$496M	Buy	3,504,039 +239,722	+7%	+$32.1M	0.24%	80
2015 Q4	$463M	Sell	3,264,317 -399,823	-11%	-$53.3M	0.23%	86
2015 Q3	$448M	Buy	3,664,140 +342,461	+10%	+$44.6M	0.23%	86
2015 Q2	$431M	Buy	3,321,679 +121,862	+4%	+$15.9M	0.22%	95
2015 Q1	$430M	Buy	3,199,817 +250,442	+8%	+$32.3M	0.21%	95
2014 Q4	$370M	Buy	2,949,375 +75,455	+3%	+$9.17M	0.19%	105
2014 Q3	$350M	Sell	2,873,920 -2,862,260	-50%	-$348M	0.19%	105
2014 Q2	$677M	Buy	5,736,180 +2,885,536	+101%	+$340M	0.18%	109
2014 Q1	$343M	Sell	2,850,644 -200,724	-7%	-$23.9M	0.19%	105
2013 Q4	$340M	Buy	3,051,368 +39,418	+1%	+$3.92M	0.2%	103
2013 Q3	$278M	Sell	3,011,950 -49,896	-2%	-$4.51M	0.16%	125
2013 Q2	$259M	Buy	+3,061,846	New	+$255M	0.16%	127

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank's TMO Position: Q1 2026 in Review

Norges Bank sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 5,302,863 shares — an estimated $3.07B sold.

Norges Bank first reported a position in TMO in Q2 2013 and held it in 50 quarters. The position peaked at $3.46B in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Norges Bank reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 5,302,863 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.07B.
Norges Bank first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 50 quarters.
Norges Bank's Thermo Fisher Scientific position peaked at $3.46B in Q3 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.